Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
Authors
Keywords
Atrial Fibrillation, Warfarin, International Normalize Ratio, National Health Service, Dabigatran
Journal
PHARMACOECONOMICS
Volume 31, Issue 11, Pages 971-980
Publisher
Springer Nature
Online
2013-10-01
DOI
10.1007/s40273-013-0090-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- Greater Stroke Severity Predominates over All Other Factors for the Worse Outcome of Cardioembolic Stroke
- (2013) Keun-Sik Hong et al. Journal of Stroke & Cerebrovascular Diseases
- Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium
- (2013) Hanne Wouters et al. JOURNAL OF MEDICAL ECONOMICS
- Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
- (2012) Soyon Lee et al.
- Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
- (2012) Thomas Davidson et al. EUROPEAN HEART JOURNAL
- Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance
- (2012) Yousif Ahmad et al. HEART
- Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
- (2012) H. Kamel et al. NEUROLOGY
- Subclinical Atrial Fibrillation and the Risk of Stroke
- (2012) Jeff S. Healey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. PLoS One
- Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
- (2012) José R. González-Juanatey et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
- (2012) Hooman Kamel et al. STROKE
- Progress for Stroke Prevention With Atrial Fibrillation
- (2012) Michael Katsnelson et al. STROKE
- Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
- (2012) Michael Sharma et al. THROMBOSIS AND HAEMOSTASIS
- Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark
- (2012) Lars K Langkilde et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
- (2011) Anuraag Kansal et al. THROMBOSIS AND HAEMOSTASIS
- Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries
- (2010) E. Holstenson et al. EUROPACE
- New oral anticoagulant drugs in cardiovascular disease
- (2010) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
- (2008) A. Ringborg et al. EUROPACE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now